Nonalcoholic fatty pancreas disease: role in metabolic syndrome,“prediabetes,” diabetes and atherosclerosis

TD Filippatos, K Alexakis, V Mavrikaki… - Digestive diseases and …, 2022‏ - Springer
Fat accumulation in the pancreas associated with obesity and the metabolic syndrome
(MetS) has been defined as “non-alcoholic fatty pancreas disease”(NAFPD). The aim of this …

[PDF][PDF] Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!

N Katsiki, M Banach, D Mikhailidis - Archives of Medical Science, 2019‏ - termedia.pl
In the last several years there has been a large debate whether patients with type 2 diabetes
(T2DM) should be treated as those with high or very high cardiovascular risk, and whether …

Perirenal adiposity and other excessive intra-and peri-organ fat depots: what is the connection?

N Katsiki, G Dimitriadis, DP Mikhailidis - Angiology, 2019‏ - journals.sagepub.com
In this issue of Angiology, Liu et al1 reviewed the role of perirenal fat as an emerging
cardiovascular (CV) risk factor. The authors concluded that excessive perirenal adiposity …

Bile-ology: from bench to bedside

L **, ZP Fang, M Fan, W Huang - Journal of Zhejiang University-Science …, 2019‏ - Springer
Bile acids (BAs) are originally known as detergents essential for the digestion and
absorption of lipids. In recent years, extensive research has unveiled new functions of BAs …

Dietary sodium intake in relation to non-alcoholic fatty liver disease risk: a case-control study

H Emamat, H Farhadnejad, M Movahedian… - Nutrition & Food …, 2021‏ - emerald.com
Purpose Data on relationship between dietary intake of sodium and non-alcoholic fatty liver
disease (NAFLD) risk are scarce. This paper aims to find the possible association between …

The association between liver histology and cardiovascular risk: time to introduce steatotic liver disease screening in high-risk patient groups?

C Boutari, VG Athyros - Angiology, 2024‏ - journals.sagepub.com
In this issue of Angiology, He et al. compared the predictive value of the non-alcoholic fatty
liver disease (NAFLD) fibrosis score (NFS), fibrosis-8 (FIB-8) and FIB-4 scores, among 1576 …

[HTML][HTML] Liver fibrosis as an independent cardiovascular risk factor in non-alcoholic fatty liver disease

DV Garbuzenko - Journal of Translational Gastroenterology, 2024‏ - xiahepublishing.com
This review summarizes the current investigations that confirm the significance of liver
fibrosis (LF) as an independent cardiovascular risk factor in non-alcoholic fatty liver disease …

[HTML][HTML] Enfermedad de hígado graso no alcohólico y enfermedad cardiovascular

GC Flores - Enfermedad de hígado graso no alcohólico. Un …, 2024‏ - books.google.com
La enfermedad de hígado graso no alcohólico-EHGNA-está fuertemente asociada a
obesidad y diabetes mellitus tipo 2. El espectro de la EHGNA va desde hallazgos …

[PDF][PDF] Non-invasive measures of liver fibrosis in NAFLD is associated with cardiovascular risk

D Niederseer, S Bachmayer… - J …, 2019‏ - s3.eu-central-1.amazonaws.com
Methods: We screened 2138 asymptomatic subjects (59.6±10.2 years, 50% males, BMI
27.2±4.6 kg/m²). The diagnosis of NAFLD was labeled if 1.(Areas of significant increased …

Follow-up of two personalized energy-restricted dietary strategies in subjects with nonalcoholic fatty liver disease: Underlying nutritional and lifestyle factors

BA Marin-Alejandre - 2021‏ - dadun.unav.edu
Nonalcoholic fatty liver disease (NAFLD) prevalence is estimated around 25% worldwide
being related to the growing rates of obesity, type 2 diabetes mellitus, and cardiovascular …